There are no randomized controlled trials that support the United States Preventive Services Task Force guideline on screening for depression in primary care: a systematic review

BackgroundThe United States Preventive Services Task Force (USPSTF) recommends screening adults for depression in primary care settings when staff-assisted depression management programs are available. This recommendation, however, is based on evidence from depression management programs conducted with patients already identified as depressed, even though screening is intended to identify depressed patients not already recognized or treated. The objective of this systematic review was to evaluate whether there is evidence from randomized controlled trials (RCTs) that depression screening benefits patients in primary care, using an explicit definition of screening.MethodsWe re-evaluated RCTs included in the 2009 USPSTF evidence review on depression screening, including only trials that compared depression outcomes between screened and non-screened patients and met the following three criteria: determined patient eligibility and randomized prior to screening; excluded patients already diagnosed with a recent episode of depression or already being treated for depression; and provided the same level of depression treatment services to patients identified as depressed in the screening and non-screening trial arms. We also reviewed studies included in a recent Cochrane systematic review, but not the USPSTF review; conducted a focused search to update the USPSTF review; and reviewed trial registries.ResultsOf the nine RCTs included in the USPSTF review, four fulfilled none of three criteria for a test of depression screening, four fulfilled one of three criteria, and one fulfilled two of three criteria. There were two additional RCTs included only in the Cochrane review, and each fulfilled one of three criteria. No eligible RCTs were found via the updated review.ConclusionsThe USPSTF recommendation to screen adults for depression in primary care settings when staff-assisted depression management programs are available is not supported by evidence from any RCTs that are directly relevant to the recommendation. The USPSTF should re-evaluate this recommendation.Please see related article: http://www.biomedcentral.com/1741-7015/12/14RegistrationPROSPERO (#CRD42013004276)

[1]  A. Montejo,et al.  Systematic depression screening in high-risk patients attending primary care: a pragmatic cluster-randomized trial , 2013, BMC Psychiatry.

[2]  Mark Olfson,et al.  Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. , 2011, Health affairs.

[3]  M. Olfson,et al.  National patterns in antidepressant medication treatment. , 2009, Archives of general psychiatry.

[4]  Blair T. Johnson,et al.  Rethinking recommendations for screening for depression in primary care , 2012, Canadian Medical Association Journal.

[5]  C. Mulrow,et al.  Case-finding for depression in primary care: a randomized trial. , 1999, The American journal of medicine.

[6]  B. Penninx,et al.  Longitudinal Evidence for Unfavorable Effects of Antidepressants on Heart Rate Variability , 2010, Biological Psychiatry.

[7]  H. Ruhé,et al.  Screening for depression in high-risk groups: prospective cohort study in general practice , 2009, British Journal of Psychiatry.

[8]  C. Sherbourne,et al.  Five-year impact of quality improvement for depression: results of a group-level randomized controlled trial. , 2004, Archives of general psychiatry.

[9]  C. Dowrick,et al.  Medicalising unhappiness: new classification of depression risks more patients being put on drug treatment from which they will not benefit , 2013, BMJ.

[10]  C. Dowrick,et al.  Twelve month outcome of depression in general practice: does detection or disclosure make a difference? , 1995, BMJ.

[11]  Kathleen N Lohr,et al.  Screening for Depression in Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[12]  J. Ockene,et al.  Screening for depression in adults: U.S. preventive services task force recommendation statement. , 2009, Annals of internal medicine.

[13]  L. Rubenstein,et al.  A Randomized Trial of a Screening, Case Finding, and Referral System for Older Veterans in Primary Care , 2007, Journal of the American Geriatrics Society.

[14]  E. Latimer,et al.  The Costs Associated with Antidepressant Use in Depression and Anxiety in Community-Living Older Adults , 2013, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[15]  T. Sheldon,et al.  Screening and case-finding instruments for depression: a meta-analysis , 2008, Canadian Medical Association Journal.

[16]  N. Anderson,et al.  Diagnosis and treatment of depression following routine screening in patients with coronary heart disease or diabetes: a database cohort study , 2012, Psychological Medicine.

[17]  G. Bergus,et al.  The limited effect of screening for depressive symptoms with the PHQ-9 in rural family practices. , 2005, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.

[18]  Pim Cuijpers,et al.  Does pretreatment severity moderate the efficacy of psychological treatment of adult outpatient depression? A meta-analysis. , 2010, Journal of consulting and clinical psychology.

[19]  C. Labos,et al.  Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction , 2011, Canadian Medical Association Journal.

[20]  W M Tierney,et al.  Improving Treatment of Late Life Depression in Primary Care: A Randomized Clinical Trial , 1994, Journal of the American Geriatrics Society.

[21]  P. Nutting,et al.  Managing depression as a chronic disease: a randomised trial of ongoing treatment in primary care , 2002, BMJ : British Medical Journal.

[22]  R Mann,et al.  Methods to identify postnatal depression in primary care: an integrated evidence synthesis and value of information analysis. , 2009, Health technology assessment.

[23]  B. Gaynes,et al.  Screening for Depression in Adult Patients in Primary Care Settings: A Systematic Evidence Review , 2009, Annals of Internal Medicine.

[24]  Blair T. Johnson,et al.  Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration , 2008, PLoS medicine.

[25]  L. Bouter,et al.  Cost-effectiveness of a disease management program for major depression in elderly primary care patients , 2006, Journal of General Internal Medicine.

[26]  G. Lewis,et al.  Computerized assessment of common mental disorders in primary care: effect on clinical outcome. , 1996, Family practice.

[27]  Mary A. Whooley,et al.  To screen or not to screen? Depression in patients with cardiovascular disease. , 2009, Journal of the American College of Cardiology.

[28]  M. Fava,et al.  Culturally sensitive collaborative treatment for depressed chinese americans in primary care. , 2010, American journal of public health.

[29]  P. Nutting,et al.  Designing and implementing a primary care intervention trial to improve the quality and outcome of care for major depression. , 2000, General hospital psychiatry.

[30]  M. Whooley,et al.  Randomized trial of case-finding for depression in elderly primary care patients , 2000, Journal of General Internal Medicine.

[31]  B. Thombs,et al.  Routine screening for depression in patients with coronary heart disease never mind. , 2009, Journal of the American College of Cardiology.

[32]  Vikram Patel,et al.  Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis , 2011, British Journal of Psychiatry.

[33]  C. Del Mar,et al.  Analysis of decisions made in meta-analyses of depression screening and the risk of confirmation bias: A case study , 2012, BMC Medical Research Methodology.

[34]  P. Souverein,et al.  Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. , 2008, Archives of internal medicine.

[35]  J. Zeber,et al.  The cost-utility of screening for depression in primary care. , 2001, Annals of internal medicine.

[36]  U. Bergman,et al.  Inhibition of metoprolol metabolism and potentiation of its effects by paroxetine in routinely treated patients with acute myocardial infarction (AMI) , 2008, European Journal of Clinical Pharmacology.

[37]  Martin Fortin,et al.  Canadian Task Force on Preventive Health Care , 2012 .

[38]  C. Sherbourne,et al.  Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. , 2000, JAMA.

[39]  Tracy L Beil,et al.  Screening for Depression in Adults and Older Adults in Primary Care , 2009 .

[40]  Robyn M Leventhal,et al.  Severity of Depression and Response to Antidepressants and Placebo: An Analysis of the Food and Drug Administration Database , 2002, Journal of clinical psychopharmacology.

[41]  N. Khin,et al.  Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications. , 2011, The Journal of clinical psychiatry.

[42]  K. Pottie,et al.  Recommendations on screening for depression in adults , 2013, Canadian Medical Association Journal.

[43]  Screening for depression: recommendations and rationale. , 2002 .

[44]  T. Sheldon,et al.  Screening and case finding instruments for depression. , 2005, The Cochrane database of systematic reviews.

[45]  Simon Gilbody,et al.  Should we screen for depression? , 2006, BMJ : British Medical Journal.

[46]  R. DeRubeis,et al.  Antidepressant drug effects and depression severity: a patient-level meta-analysis. , 2010, JAMA.

[47]  R. Steele,et al.  Risk of bias from inclusion of patients who already have diagnosis of or are undergoing treatment for depression in diagnostic accuracy studies of screening tools for depression: systematic review , 2011, BMJ : British Medical Journal.

[48]  N. Duan,et al.  Improving depression outcomes in community primary care practice , 2001, Journal of General Internal Medicine.

[49]  Alfred O. Berg,et al.  Screening for Depression: Recommendations and Rationale , 2002, Annals of Internal Medicine.

[50]  J. Coyne,et al.  Screening for depression in medical care: pitfalls, alternatives, and revised priorities. , 2003, Journal of psychosomatic research.

[51]  M. Olfson,et al.  National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the national comorbidity survey replication. , 2008, The Journal of clinical psychiatry.

[52]  Alisa B. Busch,et al.  New Jersey's efforts to improve postpartum depression care did not change treatment patterns for women on medicaid. , 2011, Health affairs.

[53]  B. Yawn,et al.  TRIPPD: A Practice-Based Network Effectiveness Study of Postpartum Depression Screening and Management , 2012, The Annals of Family Medicine.

[54]  R. Mojtabai.  Clinician-Identified Depression in Community Settings: Concordance with Structured-Interview Diagnoses , 2013, Psychotherapy and Psychosomatics.

[55]  Dr Christine Hill.  An evaluation of screening for postnatal depression against NSC criteria , 2011 .

[56]  S. Stahl,et al.  SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants , 2005, CNS Spectrums.

[57]  B. Levis,et al.  Does Evidence Support the American Heart Association's Recommendation to Screen Patients for Depression in Cardiovascular Care? An Updated Systematic Review , 2013, PloS one.

[58]  D. Streiner,et al.  Why screening for depression in primary care is impractical , 2013, Canadian Medical Association Journal.

[59]  Mary A Whooley,et al.  Depression screening and patient outcomes in cardiovascular care: a systematic review. , 2008, JAMA.

[60]  B. Yawn,et al.  Screening for depression in adults: U.S. Preventive Services Task Force recommendation statement , 2009 .

[61]  K. Shojania,et al.  Surveillance search techniques identified the need to update systematic reviews. , 2008, Journal of clinical epidemiology.

[62]  Edoardo Spina,et al.  Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. , 2008, Clinical therapeutics.

[63]  M. Olfson,et al.  National trends in the treatment for depression from 1998 to 2007. , 2010, Archives of general psychiatry.

[64]  D. Jarjoura,et al.  Effectiveness of screening and treatment for depression in ambulatory indigent patients , 2007, Journal of General Internal Medicine.

[65]  C. Dowrick,et al.  Does testing for depression influence diagnosis or management by general practitioners? , 1995, Family practice.

[66]  Tania M Wilkins,et al.  Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder , 2011, Annals of Internal Medicine.

[67]  S. Palmer,et al.  Screening for postnatal depression in primary care: cost effectiveness analysis , 2009, BMJ : British Medical Journal.

[68]  Sean Hennessy,et al.  Antidepressant-Warfarin Interaction and Associated Gastrointestinal Bleeding Risk in a Case-Control Study , 2011, PloS one.